市場調査レポート
商品コード
1416700
肝がん診断市場レポート:2030年までの動向、予測、競合分析Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
肝がん診断市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
世界の肝がん診断市場は、2024年から2030年までのCAGRが6.2%で、2030年までに推定110億米ドルに達すると予想されています。この市場の主な促進要因は、肝がん関連の発生数の増加と、迅速なスクリーニング方法とポイントオブケア検査に対する需要の増大です。世界の肝がん診断市場の将来は、病院および診断研究所、学術調査機関、製薬およびCRO研究所市場での機会があり、有望に見えます。
Lucintelは、精度と費用対効果の高さから一般大衆の間でラボテストの選好が高まっているため、ラボテストが予測期間を通じて引き続き最大のセグメントになると予測しています。
この市場では、病院と診断検査室が予測期間を通じて最大のセグメントであり続けるでしょう。
北米は、堅調なヘルスケア環境の存在、国民の間でのヘルスケア保険の採用の増加、そしてこの地域における主要企業の存在により、予測期間中に最高の成長を遂げると予想されています。
Q1.市場規模は:
A1.世界の肝がん診断市場は、2030年までに推定110億米ドルに達すると予想されています。
Q2.市場の成長予測は:
A2.世界の肝がん診断市場は、2024年から2030年にかけて6.2%のCAGRで成長すると予想されています。
Q3.市場の成長に影響を与える主な促進要因は:
A3.この市場の主な促進要因は、肝がん関連の発生数の増加と、迅速なスクリーニング方法とポイントオブケア検査に対する需要の増大です。
Q4.市場の主要セグメントは:
A4.肝がん診断市場の将来は、病院および診断研究所、学術調査機関、製薬およびCRO研究所市場での機会があり、有望に見えます。
Q5.市場の主要企業は:
A5.主要な肝がん診断会社は次のとおりです。
Q6.今後、最大となる市場セグメントは:
A6.Lucintelは、精度と費用対効果の高さから一般大衆の間でラボテストの選好が高まっているため、ラボテストが予測期間を通じて引き続き最大のセグメントになると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は:
A7.北米は、堅調なヘルスケア環境の存在、国民の間でのヘルスケア保険の採用の増加、そしてこの地域における主要企業の存在により、予測期間中に最高の成長を遂げると予想されています。
Q8.レポートのカスタマイズは可能か:
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
The future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global liver cancer diagnostic by test type, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver cancer diagnostic companies profiled in this report include-
Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.
Within this market, hospitaland diagnostic laboratory will remain the largest segment over the forecast period.
North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.
Market Size Estimates: Liver cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Liver cancer diagnostic market size by test type, end use, and region in terms of value ($B).
Regional Analysis: Liver cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different test types, end uses, and regions for the liver cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
Q1. What is the liver cancer diagnostic market size?
Answer: The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030.
Q2. What is the growth forecast for liver cancer diagnostic market?
Answer: The global liver cancer diagnostic market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the liver cancer diagnostic market?
Answer: The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
Q4. What are the major segments for liver cancer diagnostic market?
Answer: The future of the liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets.
Q5. Who are the key liver cancer diagnostic market companies?
Answer: Some of the key liver cancer diagnostic companies are as follows:
Q6. Which liver cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.
Q7. In liver cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.